Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: J Neuroimmune Pharmacol. 2014 May 21;9(4):522–532. doi: 10.1007/s11481-014-9547-z

Fig. 1.

Fig. 1

(A) % FoxP3 TSDR demethylation in ND PBMC (n=10), isolated CD4+ T cells, and isolated CD4+CD25+ T cells. (B) % FoxP3 TSDR demethylation in HAM/TSP PBMC (n=9), isolated CD4+ T cells, and isolated CD4+CD25+ T cells. The long horizontal bars represent the mean for each group while the shorter bars represent the standard deviation. (C) A comparison of the %CD4+CD25+ in CD3+ T cells of ND and HAM/TSP PBMC. (D) Normalized % FoxP3 TSDR demethylation in isolated CD4+CD25+ T cells of ND and HAM/TSP patients. % FoxP3 TSDR demethylation was normalized to the % CD4+CD25+. (E) Normalized % FoxP3 TSDR demethylation in PBMC of ND and HAM/TSP patients. % FoxP3 TSDR demethylation was normalized to the % CD4+CD25+.